Knowing when your Ozempic® pen is empty is harder than it looks, because an Ozempic® pen never looks empty. There is always a little liquid left in the cartridge when the last dose has been delivered, and that leftover is the single biggest source of confusion for people taking weekly semaglutide — on a diabetes prescription or as part of a semaglutide weight-loss dosing schedule.
The pen does tell you what is left, but not in the way most people assume. The dose counter is not a fuel gauge. It shows the dose you have dialed up, not the amount remaining in the cartridge. There is a specific check, described in Novo Nordisk’s FDA-approved Instructions for Use, that answers the question properly — and it takes about five seconds.
This guide covers that check, how many doses each pen actually contains, why the leftover liquid is not a bonus dose, when a pen should be thrown away even if medicine is still in it, and what to do when you reach the end of a pen.
There are three reliable signs, and several unreliable ones that are worth knowing about because they are widely repeated.
Reliable: the dose counter stops before your prescribed dose when you turn the dose selector; you have injected the number of doses the pen holds; or the pen has been in use for 56 days, which means it is finished regardless of what is left inside.
Unreliable: how much liquid you can see through the pen window, and whether you hear a click. The pen clicks every time you turn the dose selector, and you may hear or feel a click at the end of a perfectly normal injection when the counter returns to zero. A click tells you nothing about whether the pen is empty.
It does, but it is not the window and it is not a running total. The pen has a dose counter and a dose pointer, and together they show the dose currently selected. To find out how much medicine is left, you use the counter in a particular way:
That is the entire method. The pen is designed so it physically cannot dial up a dose it cannot deliver, which is why the counter stopping early is a dependable answer and a glance through the window is not.
Each Ozempic® pen delivers four injections, with one exception worth understanding: the starting pen can be used either for the introductory dose or for the next step up, so it can stretch to six weeks in the first phase of treatment.
| Pen | Dose it delivers | Doses per pen | Weeks covered |
|---|---|---|---|
| 2 mg / 3 mL (starting pen) | 0.25 mg or 0.5 mg | Four 0.25 mg doses plus two 0.5 mg doses, or four 0.5 mg doses | 4–6 |
| 4 mg / 3 mL | 1 mg only | Four | 4 |
| 8 mg / 3 mL | 2 mg only | Four | 4 |
Because Ozempic® is a once-weekly injection, a simple habit answers the question before it becomes urgent: note the date of the first injection from each new pen, count four weeks forward, and order the refill in week three.
Because it is supposed to. Every pen is filled with slightly more liquid than the doses it delivers, so that each of those doses is complete. The medicine you can still see after the last injection is that surplus. It is not a spare dose, and there is no accurate way to measure or use it.
Think of it like the fuel pump at a filling station. The hose is never dry when the pump shuts off, and nobody tries to shake the last drops out of it.
This misunderstanding has caused real harm. A case report published in September 2026 described a man taking weekly semaglutide at the 2.4 mg dose who injected his dose, saw liquid still in the cartridge, concluded the injection had failed, and kept injecting until the pen emptied. He received 9.6 mg — four weekly doses at once.
He had no nausea or vomiting at all. What he developed, about two days later, was widespread burning skin sensations and marked weakness that took a week to settle. Two lessons for anyone using a pen: leftover liquid is expected, and an accidental extra dose does not always announce itself with sickness.
Never inject more than the dose you dialed in order to use up what you can see, and never use a syringe to withdraw medicine from a pen. The Instructions for Use state this directly. If you think you have taken too much, contact your healthcare provider or a poison control center, even if you feel fine.
No. Once the pen cannot dial up a full dose, it has nothing useful left to give. Injecting what remains means injecting an unknown, incomplete amount, which is the same as skipping part of your dose without knowing by how much.
The same applies to a pen that has passed 56 days of use. Even if the counter still stops on your dose, the pen is finished and should be disposed of. That 56-day limit is about how long the medicine stays reliable after the first injection, not about how much is left.
There is, but not in the way it is often described. The pen will not let you dial a dose it cannot complete — the counter simply stops early. The risk of a partial dose comes from three other places:
No, and this is worth being clear about, because click-counting charts circulate widely online. The Instructions for Use address it twice: “Do not set the dose by counting the number of clicks you hear,” and “The dose selector clicks differently when turned forward or backward. Do not count the pen clicks.” The dose counter and dose pointer are the only accurate guide to what the pen will deliver.
In January 2025, the Institute for Safe Medication Practices published a patient warning about dosing GLP-1 pens by counting clicks. Its concerns were practical: the amount actually being taken stops matching the prescription on file, miscounting is easy when the count runs to 36 or 54, and stretching a pen out over extra weeks can leave people short of clean needles — or still injecting from a pen that passed its 56-day limit. If cost or side effects are the reason you are thinking about it, that is a conversation to have with your prescriber, who can adjust the prescription properly.
Replace it promptly, because weekly treatment works best without gaps, and handle the old pen safely:
Unused pens live in the refrigerator, between 36°F and 46°F, until their expiration date. A pen that is in use can be kept either in the refrigerator or at room temperature between 59°F and 86°F, and lasts 56 days from the first injection. Do not freeze a pen, and do not use one that has been frozen. There is more detail in our guide to whether Ozempic® needs to be refrigerated. You do not need to warm a cold pen for a set number of minutes before injecting; the instructions do not call for it, though many people find a pen at room temperature more comfortable to use. Injection site technique matters more for comfort — see where GLP-1 injections can be given.
Look through the pen window before every injection. Ozempic® should be clear and colorless. If it looks cloudy or contains particles, do not use that pen — speak to your pharmacist.
A small bubble is common and is not the reason a dose failed. Novo Nordisk’s instructions for the single-dose prefilled syringe say plainly that air bubbles are normal, do not affect the dose, and should not be removed. With the pen, the thing that confirms medicine is flowing is the drop that appears at the needle tip during the flow check on a new pen.
No. The flow check is done once for each new pen, before its first injection. Repeating it before every dose wastes medicine and can leave a pen short.
That is the pen doing its job. It is telling you there is not enough medicine left for a full dose. Start a new pen.
Worth a moment’s attention, because the first question about a pen is whether it is a real one. The FDA has warned three times about counterfeit Ozempic® reaching the US supply chain — in December 2023, again in April 2025, and most recently in December 2025 — each involving the 1 mg strength. In the December 2025 batch, the tell was the label layout: on the counterfeit cartons and pens the “EXP/LOT” text sits to the left of the date and lot number, while on genuine product it sits above them. Counterfeit needles have also been found, and their sterility cannot be confirmed. Buy only from a state-licensed pharmacy with a valid prescription, and check the pen against the FDA notice if anything about the packaging looks unfamiliar.
Two changes are worth knowing about, because both affect what “is it empty?” even means.
Ozempic® is no longer only a dial-a-dose pen. The May 2026 labeling added single-dose prefilled syringes in 0.25 mg, 0.5 mg and 1 mg. A syringe has no dial and no dose counter: it holds one complete dose, is used once, and goes straight into the sharps container. If you have been switched to syringes, the checks on this page do not apply — you simply use one syringe per weekly dose, and air bubbles in it are normal.
There is now an Ozempic® tablet. The oral semaglutide tablets previously sold as Rybelsus® were rebranded to Ozempic® in January 2026 and reached US pharmacies in May 2026, in 1.5 mg, 4 mg and 9 mg strengths. If you are weighing one against the other, our comparison of oral and injectable semaglutide covers the differences.
Once a week is enough, because this is a once-weekly injection. Do the counter check before you inject, not after — that way, if the counter stops short, you can open a new pen and take your dose on schedule instead of discovering the problem with a needle already in your skin.
Yes, and they are the most underused resource in this whole process. A pharmacist can watch you run through the counter check and the flow check, confirm you are getting a complete dose, flag when a refill is due, and answer questions about storage and disposal without an appointment. If anything on this page does not match the pen in your hand, take the pen to the pharmacy counter.
Device handling is where a lot of GLP-1 treatment quietly goes wrong, and most of it is invisible at follow-up unless you ask directly. A few things worth building into the visit:
Practices building or expanding a medical weight-management service can cover this and the rest of the GLP-1 clinical pathway in IAPAM’s CME-accredited GLP-1 certification training.
IAPAM’s GLP-1 certification training covers patient selection, titration, side-effect management, device and injection counseling, and the business of running a medical weight-management program — taught by practicing physician faculty.
Eligibility: MD/DO, NP, APRN/CRNA, PA, DMD/DDS, RN
What the program covers
Turn the dose selector forward until the dose counter stops. If it stops on your dose, there is at least that much left in the pen. If it stops before your dose, there is not enough medicine for a full dose and you should start a new pen. Do not judge by how much liquid you can see, and do not count clicks.
Every pen is filled with slightly more liquid than the doses it delivers, so a pen never looks empty, even after the last dose. Liquid left in the cartridge is normal and is not an extra dose. Never inject more than the dose you dialed to use it up, and never draw medicine out of the pen with a syringe.
The 2 mg/3 mL pen delivers four doses of 0.25 mg followed by two doses of 0.5 mg, or four doses of 0.5 mg. The 4 mg/3 mL pen delivers four doses of 1 mg. The 8 mg/3 mL pen delivers four doses of 2 mg. Because Ozempic® is injected once a week, most pens cover four weeks.
A pen in use should be discarded 56 days after its first injection, even if medicine is still in it. Unused pens are stored in the refrigerator at 36°F to 46°F until their expiration date. A pen in use can be kept in the refrigerator or at room temperature, 59°F to 86°F.
No. The Instructions for Use say not to set a dose by counting clicks, because the pen clicks differently turning forward and backward and clicks do not measure a dose. The dose counter and dose pointer are the only accurate guide. Ask your prescriber or pharmacist before changing how you use a pen.
Contact your healthcare provider or a poison control center straight away, even if you feel well. Symptoms of an accidental extra dose can be delayed and may not include nausea. Do not try to compensate by skipping or changing later doses on your own.
An Ozempic® pen tells you exactly what it has left, as long as you ask it the right question. Turn the dial until the counter stops; if it stops short of your dose, the pen is done. Ignore the window, ignore the clicks, keep track of the 56 days, and keep a spare pen in the refrigerator so the end of one is never the reason a week gets missed.
For clinicians, this is one small part of running a GLP-1 service well — and the part patients are most likely to get wrong at home. IAPAM’s GLP-1 certification training for medical weight management covers the clinical protocols, the patient counseling and the business foundations together.
Explore GLP-1 Certification Training
Disclaimer: This guide is for informational and educational purposes only and does not constitute medical advice. It does not replace the Instructions for Use supplied with your pen or the guidance of your prescriber or pharmacist. Dosing, device training and treatment decisions must be individualized by a qualified, licensed provider. Always follow product labeling, your scope of practice, and your state medical and nursing board regulations.
Hands-On Aesthetic Medicine Training
Gain the confidence to start seeing patients right away.
Attend IAPAM’s comprehensive AMA PRA Category 1 CME BOTOX® training weekend and learn the clinical and business foundations for aesthetic practice growth.
Click the image to explore upcoming BOTOX® training.
Terms and conditions apply. Offer expires October 31.